Clinical Study to Assess the Efficacy of a Topical Acne Product

  • STATUS
    Recruiting
Updated on 2 September 2022

Summary

Validated Claim Support (VCS) is searching for individuals 18 years and older who suffer from mild to moderate acne, to test acne products and get paid for your opinion and time. All subjects must have current visible active acne blemishes and will be fairly compensated. Please Note: Requirements are study specific which determines your eligibility. Subjects will be fairly compensated upon completion.

Description

Validated Claim Support is recruiting subjects to assess the efficacy of topical acne products. Potential subjects will arrive at the test site and will undergo screening procedures. Subjects will be asked to read and sign an informed consent form, complete or update personal/medical history and will be screened for qualification using an Inclusion/Exclusion criteria checklist. Subjects that meet entrance criteria will receive test product assigned to them per randomization, per Sponsor instructions for a given time period. Sponsor-provided instructions will be explained to subjects and provided to subjects in writing along with a daily product log to record use. Additional study use instructions will be dispersed at the time of enrollment. Subjects will be fairly compensated upon completion. For more information, visit our GET PAID section of our website. 

Details
Condition Acne
Clinical Study IdentifierTX306109
Last Modified on2 September 2022

Eligibility

Yes No Not Sure

Inclusion Criteria

Female and/or Male subjects of any race, in good general health, aged 18-65 years old, inclusive at enrollment
Individuals who are able to cooperate with the Principal Investigator and study personnel throughout the duration of the study and are willing to comply with all study procedures, methods, evaluations, and study product use
Individuals who are able to read, understand and willing to sign an informed consent for this specific study and have completed all site required documentation prior to study enrollment (Registration and Medical History)
Individuals willing to be photographed and sign a model release
Individuals with mild to moderate acne (minimum of 3 lesions, at least 1 inflammatory)

Exclusion Criteria

Individuals who are currently using prescription (topical or oral) acne medications
Individuals who are using over the counter acne treatment products
Individuals with acute or chronic disease(s) or medical condition(s), including dermatological problems, which could put them at risk in the opinion of the Principal Investigator or compromise the study outcome. Typical uncontrolled chronic or serious diseases and conditions which would prevent participation in any clinical study are cancer, AIDS, insulin-dependent diabetes, renal impairment, mental illness, and/or drug/alcohol addiction
Individuals with a history of melanoma, or a treated skin cancer within the last 5 years
Individuals who are pregnant, lactating, or planning to become pregnant. Individuals who become pregnant during the study must inform the Principal Investigator immediately
Individuals who are unreliable or unlikely to be available for the duration of the study
Individuals with a history of allergic reactions, skin sensitization and/or known allergies to cosmetic and personal care products/ingredients
Individuals who are immunocompromised
Individuals who are employees of VCS or other testing firms/laboratories, cosmetic or raw goods manufacturers or suppliers
Individuals who are unable to communicate or cooperate with the Principal Investigator/study personnel due to language problems, poor mental development, or impaired cerebral function
Individuals who started Hormone Replacement Therapy within the last three months preceding the commencement of the study
Individuals who are using oral contraception for less than three months before study commencement or who have changed their contraceptive method within the three months before the Baseline visit or planning to modify their contraception treatment within the duration of the study
Individuals who have traveled (domestically or internationally) 5 days prior to any visit throughout the study
Individuals with COVID-19 related symptoms, per CDC, within 48 hours prior to any visit throughout the study
Individuals who have used a fever reducer within 12 hours prior to any site visit
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note